Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

E-Prescribing Pilot Participants To Report Generic, On-Formulary Drug Use

Executive Summary

The Centers for Medicare & Medicaid Services is requiring that participants in its electronic prescribing pilot program report use of on-formulary medications and generics

You may also be interested in...



Prior Authorization In E-Prescribing To Be Subject Of Caremark Pilot Programs

Caremark will be pilot testing the use of electronic prescribing transactions that require prior authorization

Prior Authorization In E-Prescribing To Be Subject Of Caremark Pilot Programs

Caremark will be pilot testing the use of electronic prescribing transactions that require prior authorization

Drug Firms Seek Ways To Donate E-Prescribing Equipment To Physicians

The Pharmaceutical Research & Manufacturers of America is seeking the inclusion of manufacturers in the HHS Inspector General's safe harbor for donations of e-prescribing equipment

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046404

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel